Evatanepag (CP-533536) is a non-prostanoid, potent and selective EP2 receptor agonist. Evatanepag can induce local bone formation in vivo. Evatanepag can be used in the research of fractures, bone defects, asthma[1][2].
Molecular Weight:
468.57
Purity:
99.78
CAS Number:
[223488-57-1]
Formula:
C25H28N2O5S
Target:
Prostaglandin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
